Raymond James Financial Services Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.45M | Sell |
|
|||||
|
2024
Q2 | $1.47M | Sell |
|
|||||
|
2024
Q1 | $2.39M | Sell |
|
|||||
|
2023
Q4 | $3.15M | Sell |
|
|||||
|
2023
Q3 | $2.97M | Sell |
|
|||||
|
2023
Q2 | $3.84M | Sell |
|
|||||
|
2023
Q1 | $9.1M | Buy |
|
|||||
|
2022
Q4 | $8.13M | Sell |
|
|||||
|
2022
Q3 | $10M | Sell |
|
|||||
|
2022
Q2 | $14.4M | Buy |
|
|||||
|
2022
Q1 | $11.1M | Sell |
|
|||||
|
2021
Q4 | $15.4M | Sell |
|
|||||
|
2021
Q3 | $25.8M | Buy |
|
|||||
|
2021
Q2 | $29.1M | Sell |
|
|||||
|
2021
Q1 | $33.3M | Buy |
|
|||||
|
2020
Q4 | $27.2M | Buy |
|
|||||
|
2020
Q3 | $11.9M | Sell |
|
|||||
|
2020
Q2 | $10.6M | Buy |
|
|||||
|
2020
Q1 | $5.14M | Buy |
|
|||||
|
2019
Q4 | $3.34M | Buy |
|
|||||
|
2019
Q3 | $1.86M | Buy |
|
|||||
|
2019
Q2 | $1.5M | Sell |
|
|||||
|
2019
Q1 | $3.46M | Buy |
|
|||||
|
2018
Q4 | $573K | Buy |
|
|||||
|
2018
Q3 | $315K | Buy |
|